日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial

CPX-351 与柔红霉素、阿糖胞苷和吉妥珠单抗治疗老年非不良风险 AML 患者的疗效比较:NCRI AML18 试验

Knapper, Steven; Dillon, Laura W; Babu, Malavika; Thomas, Abin; Thomas, Ian; Hourigan, Christopher S; Andrew, Georgia; Dillon, Richard; Gilkes, Amanda; Marquez Almuina, Nuria; King, Sophie; McCarthy, Nicholas; Bahr, Reem; Al-Ali, Rasha W; Stone, Louisa; Coats, Tom; Byrne, Jennifer; Green, Simone; Overgaard, Ulrik Malthe; Sellar, Rob S; Dennis, Mike; Mehta, Priyanka; Hills, Robert; Freeman, Sylvie D; Russell, Nigel H

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial

根据老年 AML 患者的残余疾病状态,采用氟达拉滨、阿糖胞苷、粒细胞集落刺激因子和伊达比星,或克拉屈滨联合柔红霉素和阿糖胞苷强化治疗:来自 NCRI AML18 试验的结果

Russell, Nigel H; Thomas, Abin; Hills, Robert K; Thomas, Ian; Gilkes, Amanda; Almuina, Nuria Marquez; Burns, Sarah; Marsh, Lucy; Vyas, Paresh; Metzner, Marlen; McCarthy, Nicholas; Andrew, Georgia; Byrne, Jennifer; Sellar, Rob S; Kelly, Richard; Cahalin, Paul; Overgaard, Ulrik Malthe; Mehta, Priyanka; Dennis, Mike; Knapper, Steven; Freeman, Sylvie D

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML

在FLT3突变型急性髓系白血病(AML)中,米哚妥林联合吉妥珠单抗奥佐米星治疗并进行诱导化疗的安全性和有效性研究

Russell, Nigel; Othman, Jad; Cumming, Oliver; Thomas, Abin; Tedjaseputra, Aditya; Potter, Nicola; Jovanovic, Jelena; Gilkes, Amanda; Batten, Leona; Canham, Joanna; Hinson, Emily; Runglall, Manohursingh; Aucken, Phoebe; Kottaridis, Panos; Cavenagh, Jamie; Arnold, Claire; Freeman, Sylvie; Dennis, Mike; Knapper, Steven; Dillon, Richard

A revised prognostic model for patients with acute myeloid leukemia and first relapse

急性髓系白血病首次复发患者的修订预后模型

van der Maas, Niek G; Breems, Dimitri; Klerk, Clara P W; Pabst, Thomas; Gradowska, Patrycja; Thomas, Abin; Biemond, Bart J; Kuball, Jurgen; Van Elssen, Catharina H M J; Visser, Otto; Vekemans, Marie-Christiane; Graux, Carlos; Maertens, Johan; Knapper, Steven; Dennis, Mike; Freeman, Sylvie; Thomas, Ian; Beverloo, H Berna; Huls, Gerwin; Craddock, Charles; Valk, Peter J M; Vyas, Paresh; Russell, Nigel; Ossenkoppele, Gert; Löwenberg, Bob; Cornelissen, Jan J; Versluis, Jurjen

Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial

针对免疫抑制且极易感染SARS-CoV-2病毒的患者,开展AZD7442联合SARS-CoV-2疫苗的适应性临床试验(RAPID-PROTECTION):一项多中心、干预性、开放标签、随机对照试验方案

Varley, Melanie; Euden, Joanne; Adams, Richard; Barnes, Eleanor; Bodman, Craig; Choy, Ernest; Cicconi, Paola; Dagley, Vivien; Ewer, Katie; Griffin, Sian; Harris, Debbie; Hill, Adrian; Hood, Kerenza; Knapper, Steven; Pringle, Shirley; Porter, Catherine; Ottensmeier, Christian H; Raisanen, Lawrence; Ray, Ruby; Tangney, Rebecca; Wilson, Keith; Nixon, Lisette Sheena; Thomas-Jones, Emma; Tuthill, Mark

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

氟达拉滨、阿糖胞苷、粒细胞集落刺激因子和伊达比星联合吉妥珠单抗可改善年轻新诊断急性髓系白血病患者的无事件生存期,并改善携带NPM1和FLT3突变患者的总生存期。

Russell, Nigel H; Wilhelm-Benartzi, Charlotte; Othman, Jad; Dillon, Richard; Knapper, Steven; Batten, Leona M; Canham, Joanna; Hinson, Emily L; Betteridge, Sophie; Overgaard, Ulrik Malthe; Gilkes, Amanda; Potter, Nicola; Mehta, Priyanka; Kottaridis, Panagiotis; Cavenagh, Jamie; Hemmaway, Claire; Arnold, Claire; Freeman, Sylvie D; Dennis, Mike

Risk Stratification in Older Intensively Treated Patients With AML

老年急性髓系白血病患者接受强化治疗的风险分层

Versluis, Jurjen; Metzner, Marlen; Wang, Ariel; Gradowska, Patrycja; Thomas, Abin; Jakobsen, Niels Asger; Kennedy, Alison; Moore, Rachel; Boertjes, Emma; Vonk, Christian M; Kavelaars, Francois G; Rijken, Melissa; Gilkes, Amanda; Schwab, Claire; Beverloo, H Berna; Manz, Markus; Visser, Otto; Van Elssen, Catharina H M J; de Weerdt, Okke; Tick, Lidwine W; Biemond, Bart J; Vekemans, Marie-Christiane; Freeman, Sylvie D; Harrison, Christine J; Cook, Jonathan A; Dennis, Mike; Knapper, Steven; Thomas, Ian; Craddock, Charles; Ossenkoppele, Gert J; Löwenberg, Bob; Russell, Nigel; Valk, Peter J M; Vyas, Paresh

Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML

维奈托克低强度疗法治疗NPM1突变型急性髓系白血病分子学失败

Jimenez-Chillon, Carlos; Othman, Jad; Taussig, David; Jimenez-Vicente, Carlos; Martinez-Roca, Alexandra; Tiong, Ing Soo; Jain, Manish; Aries, James; Cakmak, Seda; Knapper, Steven; Kristensen, Daniel Tuyet; Murthy, Vidhya; Galani, Joy Zacharoula; Kallmeyer, Charlotte; Ngu, Loretta; Veale, David; Bolam, Simon; Orfali, Nina; Parker, Anne; Manson, Cara; Parker, Jane; Erblich, Thomas; Richardson, Deborah; Mokretar, Katya; Potter, Nicola; Overgaard, Ulrik Malthe; Roug, Anne Stidsholt; Wei, Andrew H; Esteve, Jordi; Jädersten, Martin; Russell, Nigel; Dillon, Richard

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

鲁索替尼与现有最佳疗法治疗对羟基脲不耐受或耐药的真性红细胞增多症的随机试验

Harrison, Claire N; Nangalia, Jyoti; Boucher, Rebecca; Jackson, Aimee; Yap, Christina; O'Sullivan, Jennifer; Fox, Sonia; Ailts, Isaak; Dueck, Amylou C; Geyer, Holly L; Mesa, Ruben A; Dunn, William G; Nadezhdin, Eugene; Curto-Garcia, Natalia; Green, Anna; Wilkins, Bridget; Coppell, Jason; Laurie, John; Garg, Mamta; Ewing, Joanne; Knapper, Steven; Crowe, Josephine; Chen, Frederick; Koutsavlis, Ioannis; Godfrey, Anna; Arami, Siamak; Drummond, Mark; Byrne, Jennifer; Clark, Fiona; Mead-Harvey, Carolyn; Baxter, Elizabeth Joanna; McMullin, Mary Frances; Mead, Adam J

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial

吉妥珠单抗奥佐米星分次给药与单次给药治疗老年急性髓系白血病患者的获益决定因素:英国国家癌症研究所 (NCRI) AML18 试验

Freeman, Sylvie D; Thomas, Abin; Thomas, Ian; Hills, Robert K; Vyas, Paresh; Gilkes, Amanda; Metzner, Marlen; Jakobsen, Niels Asger; Kennedy, Alison; Moore, Rachel; Almuina, Nuria Marquez; Burns, Sarah; King, Sophie; Andrew, Georgia; Gallagher, Kathleen M E; Sellar, Rob S; Cahalin, Paul; Weber, Duruta; Dennis, Mike; Mehta, Priyanka; Knapper, Steven; Russell, Nigel H